Enhance your clinical knowledge of complement-mediated TMAs

Case presented: TMA three weeks postpartum

Speaker: Susan Huang, PhD, MD, FRCPC, Nephrologist, London, ON

Date: June 8, 2026

Time: 8:00 to 9:00 PM EDT

Learning objectives

After this session, participants will be better able to:

1. Differentiate aHUS from other thrombotic microangiopathies (TMAs) using appropriate clinical and biomarker tests, including genetic and complement testing
2. Select and initiate appropriate anti-complement and supportive therapies in different patient populations
3. Recognize when and how to continue, switch, or discontinue C5 inhibitor treatments as part of long-term patient management

Date: May 25-26, 2026

Location: CHU Sainte-Justine, Montreal

https://event.fourwaves.com/fr/complement2026/pages

Case presentation and hypertension in aHUS

Speaker: Dr. Christoph Licht, The Hospital for Sick Children, Canada

Moderator: Dr. Jocelyn Garland

Date: May 9, 2026

Time: 8:00 to 9:00 PM EDT

Location: Quebec City, QC

https://agm.csnscn.ca/2026-CSN-GN-Post-Day-Program

Practice Makes Progress: Key lessons from my TMA-aHUS practice

Friday May 9, 2025 • featuring: Dr. Bryce Barr, Dr. Louis Girard, and Dr. Monika Oliver

Learning objectives

1. Navigate the complex TMA diagnostic pathway
2. Identify when empiric complement inhibition might be appropriate, using available data
3. Recognize opportunities for the delivery of shared care for patients with aHUS